On Friday, June 26, the U.S. Nasdaq Biotechnology Index closed up more than 2.2%, marking a record closing high for the fifth consecutive day.

Constituent stock Pyxis Oncology closed up 24.22%, with Humacyte, ATAI Beckley, Moderna, Immunitybio Inc., GH Research, and Abcellera Biologics rising between 18.05% and 10.81%. Compass Pathways followed closely with a 9.20% increase. On the downside, Kymera closed down 7.26%, ranking fourth from the bottom, Ardelyx dropped 8.50%, Mesoblast fell 9.03%, and Omeros Corporation (OMER) plunged 19.17%.